Personalized medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction

被引：0
|
作者：
Zawadzki, P. [1 ]
Wozna, A. [1 ]
Sztromwasser, P. [2 ]
Majer-Burman, W. [2 ]
Stepien, R. [2 ]
Pacewicz, K. [2 ]
Sielski, D. [2 ]
Gniot, M. [2 ]
Wojtaszewska, M. [2 ]
Dabrowski, M. [2 ]
Piernik, M. [3 ]
机构：
[1] Adam Mickiewicz Univ, Fac Phys, Phys Biol Dept, Poznan, Poland
[2] MNM Diagnost, R&D, Poznan, Poland
[3] Poznan Univ Tech, Fac Comp & Telecommun, Poznan, Poland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.776
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1134P
引用
收藏
页码：S925 / S925
页数：1
相关论文
共 50 条
  • [1] Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer
    Echavarria, Isabel
    Jerez, Yolanda
    Martin, Miguel
    Lopez-Tarruella, Sara
    BREAST CARE, 2017, 12 (05) : 296 - 302
  • [2] CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure
    Garrido-Castro A.C.
    Goel S.
    Current Breast Cancer Reports, 2017, 9 (1) : 26 - 33
  • [3] Development of personalized medicine for breast cancer based on elucidation of resistance mechanisms to CDK4/6 inhibitors
    Kobayashi, Yoshie
    Motoi, Yusuke
    Fujimoto, Mutsumi
    Shigematsu, Hideo
    CANCER RESEARCH, 2023, 83 (05)
  • [4] Evolving treatment paradigms after CDK4/6 inhibitors in advanced breast cancer
    Gnant, Michael
    Balic, Marija
    Singer, Christian F.
    Rinnerthaler, Gabriel
    Pfeiler, Georg
    Suppan, Christoph
    Gruenberger, Birgit
    Strasser-Weippl, Kathrin
    Castagnaviz, Vanessa
    Heibl, Sonja
    Bartsch, Rupert
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2025, 18 (01) : 4 - 18
  • [5] Predicting Response to CDK4/6 Inhibitors in Breast Cancer
    Schultz, Emily
    Hamilton, Deanna
    Wang, Jianxin
    Witkiewicz, Agnieszka
    LABORATORY INVESTIGATION, 2023, 103 (03) : S208 - S208
  • [6] CDK4/6 Inhibitors in the Treatment of Metastatic Breast Cancer
    Ettl, Johannes
    Huober, Jens
    Lueftner, Diana
    Marme, Frederik
    Wuerstlein, Rachel
    BREAST CARE, 2017, 12 (02) : 118 - 120
  • [7] CDK4/6 inhibitors in advanced breast cancer, what is beyond?
    Mohammed, Amrallah A.
    Rashied, Hanaa
    Elsayed, Fifi Mostafa
    ONCOLOGY REVIEWS, 2019, 13 (02) : 125 - 133
  • [8] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [9] Targeting CDK4/6 in breast cancer
    Shanabag, Anusha
    Armand, Jessica
    Son, Eugene
    Yang, Hee Won
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2025, 57 (02): : 312 - 322
  • [10] Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
    Martin, Miguel
    Garcia-Saenz, Jose A.
    Manso, Luis
    Llombart, Antonio
    Cassinello, Alejo
    Atienza, Manuel
    Ringeisen, Francois
    Ciruelos, Eva
    FUTURE ONCOLOGY, 2020, 16 (33) : 2763 - 2778
12345